Company intelligence / Profile preview

VHsquared Ltd.

Cambridge, Cambridgeshire, United Kingdomcrunchbase.com ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Developing domain antibodies engineered for intestinal protease stability while maintaining high potency against targets. Lead compound V565 is a TNFα-neutralizing antibody resistant to intestinal proteases.

Therapeutic areas: Gastroenterology
Modalities: Domain antibodies (Vorabody™)
Industry: Biotech

Drug pipeline

3 assets

V565

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on VHsquared Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VHsquared Ltd..

Explore the full profile